An updated clinico-investigative approach to diagnosis of cutaneous hyperandrogenism in relation to adult female acne, female pattern alopecia & hirsutism a primer for dermatologists

References

• Panidis D, Tziomalos K, Papadakis E, et al. The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome. Eur J Endocrinol. 2013;168(6):871–877. doi: 10.1530/EJE-13-0039
   PubMed Web of Science ®Google Scholar
• Taylor HS, Lubna P, Seli E. In:hirsustism. Speroff’s clinical gynecologic endocrinology and Infertility. 9th ed. Philadelphia: Lippincott Williams & Wilkins; 2020. p. 1050–1062.
   Google Scholar
• Burger HG. Androgen production in women. Fertil Steril. 2002;77:S3–S5. doi: 10.1016/S0015-0282(02)02985-0
   PubMed Web of Science ®Google Scholar
• Thiboutot D, Jabara S, McAllister JM, et al. Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J Invest Dermatol. 2003;120:905–914. doi: 10.1046/j.1523-1747.2003.12244.x
   PubMed Web of Science ®Google Scholar
• Sardana K, Bansal P, Sharma LK, et al. A study comparing the clinical and hormonal profile of late onset and persistent acne in adult females. Int J Dermatol. 2020;59(4):428–433. doi: 10.1111/ijd.14748
   PubMed Web of Science ®Google Scholar
• Azzouni F, Godoy A, Li Y, et al. The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases. Adv Urol. 2012;2012:530121. doi: 10.1155/2012/530121
   PubMedGoogle Scholar
• Chen WC, Zouboulis CC. Hormones and the pilosebaceous unit. Dermatoendocrinol. 2009;1:81–86. doi: 10.4161/derm.1.2.8354
   PubMedGoogle Scholar
• Carmina E, Stanczyk FZ, Matteri RK, et al. Serum androsterone conjugates differentiate between acne and hirsutism in hyperandrogenic women. Fertil Steril. 1991;55(5):872–876. doi: 10.1016/S0015-0282(16)54290-3
   PubMed Web of Science ®Google Scholar
• Cunha MG, Martins CP, Filho CD, et al. Acne in adult women and the markers of peripheral 3 alpha-diol G activity. J Cosmet Dermatol. 2016;15:330–334. doi: 10.1111/jocd.12232
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456–488. doi: 10.1016/j.fertnstert.2008.06.035
   PubMed Web of Science ®Google Scholar
• Rosenfield RL, Lucky AW. Acne, hirsutism, and alopecia in adolescent girls. Clinical expressions of androgen excess. Endocrinol Metab Clin North Am. 1993;22:507–532. doi: 10.1016/S0889-8529(18)30148-8
   PubMed Web of Science ®Google Scholar
• Lucky AW, McGuire J, Rosenfield RL, et al. Plasma androgens in women with acne vulgaris. J Invest Dermatol. 1983;81(1):70–74. doi: 10.1111/1523-1747.ep12539043
   PubMed Web of Science ®Google Scholar
• Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev. 2000;21(4):363–392. doi: 10.1210/edrv.21.4.0404
   PubMed Web of Science ®Google Scholar
• Makrantonaki E, Zouboulis CC. Testosterone metabolism to 5alpha-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes. Br J Dermatol. 2007;156:428–432. doi: 10.1111/j.1365-2133.2006.07671.x
   PubMed Web of Science ®Google Scholar
• Vexiau P, Husson C, Chivot M, et al. Androgen excess in women with acne alone compared with women with acne and/or hirsutism. J Invest Dermatol. 1990;94(3):279–283. doi: 10.1111/1523-1747.ep12874121
   PubMed Web of Science ®Google Scholar
• Chen W, Thiboutot D, Zouboulis CC. Cutaneous androgen metabolism: basic research and clinical perspectives. J Invest Dermatol. 2002;119(5):992–1007. doi: 10.1046/j.1523-1747.2002.00613.x
   PubMed Web of Science ®Google Scholar
• Rocha M, Cardozo KHM, Carvalho VM, et al. ADT-G as a promising biomarker for peripheral hyperandrogenism in adult female acne. Dermatoendocrinol. 2017;9:e1361571. doi: 10.1080/19381980.2017.1361571
   PubMed Web of Science ®Google Scholar
• Lookingbill DP, Demers LM, Tigelaar RE, et al. Effect of isotretinoin on serum levels of precursor and peripherally derived androgens in patients with acne. Arch Dermatol. 1988;124:540–543. doi: 10.1001/archderm.1988.01670040042019
   PubMedGoogle Scholar
• Guzel AI, Kuyumcuoğlu U, Celik Y. Factors affecting the degree of hirsutism in patients with polycystic ovary syndrome. Arch Gynecol Obstet. 2012;285(3):767–770. doi: 10.1007/s00404-011-2077-5
   PubMed Web of Science ®Google Scholar
• Carmina E, Lobo RA. Evidence for increased androsterone metabolism in some normoandrogenic women with acne. J Clin Endocrinol Metab. 1993;76:1111–1114. doi: 10.1210/jc.76.5.1111
   PubMed Web of Science ®Google Scholar
• Teede HJ, Tay CT, Laven J, et al. International PCOS network. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2023;120(4):767–793. doi: 10.1016/j.fertnstert.2023.07.025.
   PubMed Web of Science ®Google Scholar
• Yildiz BO, Bolour S, Woods K, et al. Visually scoring hirsutism. Hum Reprod Update. 2010;16(1):51–64. doi: 10.1093/humupd/dmp024
   PubMed Web of Science ®Google Scholar
• Montalto J, Whorwood CB, Funder JW, et al. Plasma C19 steroid sulphate levels and indices of androgen bioavailability in female pattern androgenic alopecia. Clin Endocrinol (Oxf). 1990;32(1):1–12. doi: 10.1111/j.1365-2265.1990.tb03744.x
   PubMed Web of Science ®Google Scholar
• Sánchez P, Serrano-Falcón C, Torres JM, et al. 5α-reductase isozymes and aromatase mRNA levels in plucked hair from young women with female pattern hair loss. Arch Dermatol Res. 2018;310(1):77–83. doi: 10.1007/s00403-017-1798-0
   PubMed Web of Science ®Google Scholar
• Futterweit W, Dunaif A, Yeh HC, et al. The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. J Am Acad Dermatol. 1988;19(5):831–836. doi: 10.1016/S0190-9622(88)70241-8
   PubMed Web of Science ®Google Scholar
• Carmina E, Rosato F, Jannì A, et al. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab. 2006;91(1):2–6. doi: 10.1210/jc.2005-1457
   PubMed Web of Science ®Google Scholar
• Bermon S Manual of endocrinology and metabolism. 5th Edn. Norman Lavin: The Female Athelete; [cited 21 Jan 2023]. Available from: https://online.vitalsource.com
   Google Scholar
• Tagatz GE, Kopher RA, Nagel TC, et al. The clitoral index: a bioassay of androgenic stimulation. Obstet Gynecol. 1979;54:562–564.
   PubMed Web of Science ®Google Scholar
• Afifi L, Saeed L, Pasch LA, et al. Association of ethnicity, Fitzpatrick skin type, and hirsutism: a retrospective cross-sectional study of women with polycystic ovarian syndrome. Int J Womens Dermatol. 2017;3:37–43. doi: 10.1016/j.ijwd.2017.01.006
   PubMedGoogle Scholar
• Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens J, Haseltine F Merriam G, editors. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications; 1992. p. 377–384.
   Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25. doi: 10.1016/j.fertnstert.2003.10.004
   Web of Science ®Google Scholar
• Kumar A, Woods KS, Bartolucci AA, et al. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf). 2005;62(6):644–649. doi: 10.1111/j.1365-2265.2005.02256.x
   PubMed Web of Science ®Google Scholar
• Azziz R, Sanchez LA, Knochenhauer ES, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004;89(2):453–462. doi: 10.1210/jc.2003-031122.
   PubMed Web of Science ®Google Scholar
• Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33:1602–1618. doi: 10.1093/humrep/dey256
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Sawaya ME. Idiopathic hirsutism. Endocr Rev. 2000;21(4):347–362. doi: 10.1210/edrv.21.4.0401
   PubMed Web of Science ®Google Scholar
• Paulson RJ, Serafini PC, Catalino JA, et al. Measurements of 3 alpha,17 beta-androstanediol glucuronide in serum and urine and the correlation with skin 5 alpha-reductase activity. Fertil Steril. 1986;46:222–226. doi: 10.1016/S0015-0282(16)49515-4
   PubMed Web of Science ®Google Scholar
• Barbieri RL, Ryan KJ. Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features. Am J Obstet Gynecol. 1983;147(1):90–101. doi: 10.1016/0002-9378(83)90091-1
   PubMed Web of Science ®Google Scholar
• Nagamani M, Van Dinh T, Kelver ME. Hyperinsulinemia in hyperthecosis of the ovaries. Am J Obstet Gynecol. 1986;154(2):384–389. doi: 10.1016/0002-9378(86)90676-9
   PubMed Web of Science ®Google Scholar
• Meczekalski B, Szeliga A, Maciejewska ‐Jeske M, et al. Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism. Gynecol Endocrinol. 2021;37:677‐682. doi: 10.1080/09513590.2021.1903419
   Web of Science ®Google Scholar
• Rousset P, Gompel A, Christin-Maitre S, et al. Ovarian hyperthecosis on gray-scale and color doppler ultrasound. Ultrasound Obstet Gynecol. 2008;32:694–699. doi: 10.1002/uog.6131
   PubMed Web of Science ®Google Scholar
• Friedman CI, Schmidt GE, Kim MH, et al. Serum testosterone concentrations in the evaluation of androgen-producing tumors. Am J Obstet Gynecol. 1985;153(1):44–49. doi: 10.1016/0002-9378(85)90587-3
   PubMed Web of Science ®Google Scholar
• Yance VRV, Marcondes JAM, Rocha MP, et al. Discriminating between virilizing ovary tumors and ovary DHEAS in postmenopausal women: clinical data, hormonal profiles and image studies. Eur J Endocrinol. 2017;177:93–102. doi: 10.1530/EJE-17-0111
   PubMed Web of Science ®Google Scholar
• Derksen J, Nagesser SK, Meinders AE, et al. Identification of virilizing adrenal tumors in hirsute women. N Engl J Med. 1994;331(15):968–973. doi: 10.1056/NEJM199410133311502
   PubMed Web of Science ®Google Scholar
• Nanba AT, Rege J, Ren J, et al. 11-oxygenated C19 steroids do not decline with age in women. J Clin Endocrinol Metab. 2019;104(7):2615–2622. doi: 10.1210/jc.2018-02527
   PubMed Web of Science ®Google Scholar
• Moran C, Azziz R. 21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender. Semin Reprod Med. 2003;21:295–300.
   PubMed Web of Science ®Google Scholar
• White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000;21(3):245–291. doi: 10.1210/edrv.21.3.0398
   PubMed Web of Science ®Google Scholar
• Spritzer P, Billaud L, Thalabard JC, et al. Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia. J Clin Endocrinol Metab. 1990;70(3):642–646. doi: 10.1210/jcem-70-3-642
   PubMed Web of Science ®Google Scholar
• Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:1526‐1540. doi: 10.1210/jc.2008-0125
   Web of Science ®Google Scholar
• O’Driscoll JB, Mamtora H, Higginson J, et al. A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clin Endocrinol (Oxf). 1994;41(2):231–236. doi: 10.1111/j.1365-2265.1994.tb02535.x
   PubMed Web of Science ®Google Scholar
• Wu S, Divall S, Nwaopara A, et al. Obesity-induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cell. Diabetes. 2014;63(4):1270–1282. doi: 10.2337/db13-1514
   PubMed Web of Science ®Google Scholar
• Welt CK, Carmina E. Clinical review: lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause. J Clin Endocrinol Metab. 2013;98(12):4629–4638. doi: 10.1210/jc.2013-2375
   PubMed Web of Science ®Google Scholar
• Penttilä TL, Koskinen P, Penttilä TA, et al. Obesity regulates bioavailable testosterone levels in women with or without polycystic ovary syndrome. Fertil Steril. 1999;71(3):457–461. doi: 10.1016/S0015-0282(98)00473-7
   PubMed Web of Science ®Google Scholar
• Davis SR, Baber R, Panay N, et al. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104:4660–4666. doi: 10.1210/jc.2019-01603
   PubMed Web of Science ®Google Scholar
• Markopoulos MC, Kassi E, Alexandraki KI, et al. Management of endocrine disease: Hyperandrogenism after menopause. Eur J Endocrinol. 2015;172(2):R79–R91. doi: 10.1530/EJE-14-0468
   PubMed Web of Science ®Google Scholar
• Löfgren E, Tapanainen JS, Koivunen R, et al. Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy. Epilepsia. 2006;47:1441–1446. doi: 10.1111/j.1528-1167.2006.00506.x
   PubMed Web of Science ®Google Scholar
• Hu X, Wang J, Dong W, et al. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy. Epilepsy Res. 2011;97(1–2):73–82. doi: 10.1016/j.eplepsyres.2011.07.006
   PubMed Web of Science ®Google Scholar
• Redmond GP. Thyroid dysfunction and women’s reproductive health. Thyroid: Offic J Am Thyroid Association. 2004;14 Suppl 1:S5–S15. doi: 10.1089/105072504323024543
   PubMed Web of Science ®Google Scholar
• Krassas GE, Pontikides N, Kaltsas T, et al. Disturbances of menstruation in hypothyroidism. Clin Endocrinol (Oxf). 1999;50(5):655–659. doi: 10.1046/j.1365-2265.1999.00719.x
   PubMed Web of Science ®Google Scholar
• Schiebinger RJ, Chrousos GP, GB C Jr, et al. The effect of serum prolactin on plasma adrenal androgens and the production and metabolic clearance rate of dehydroepiandrosterone sulfate in normal and hyperprolactinemic subjects. J Clin Endocrinol Metab. 1986;62:202–209. doi: 10.1210/jcem-62-1-202
   PubMed Web of Science ®Google Scholar
• Kaltsas GA, Androulakis II, Tziveriotis K, et al. Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly. Clin Endocrinol (Oxf). 2007;67:917–922. doi: 10.1111/j.1365-2265.2007.02987.x
   PubMed Web of Science ®Google Scholar
• Abou Sherif S, Newman R, Haboosh S, et al. Investigating the potential of clinical and biochemical markers to differentiate between functional hypothalamic amenorrhoea and polycystic ovarian syndrome: a retrospective observational study. Clin Endocrinol (Oxf). 2021;95(4):618–627. doi: 10.1111/cen.14571
   PubMed Web of Science ®Google Scholar
• Carmina E, Stanczyk FZ, Lobo AR. Evaluation of hormonal status. In: Strauss F, Barbieri R, and Gargiulo A, editors. Yen & Jaffe’s reproductive endocrinology physiology, pathophysiology, and clinical. 8th ed. Vol. 34. Philadelphia: Elsevier; 2019, p. 887–915.e4.
   Google Scholar
• Salameh WA, Redor-Goldman MM, Clarke NJ, et al. Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria. Fertil Steril. 2014;101(4):1135–1141.e2. doi: 10.1016/j.fertnstert.2013.12.056
   PubMed Web of Science ®Google Scholar
• Sharma A, Kapoor E, Singh RJ, et al. Diagnostic thresholds for androgen-producing tumors or pathologic hyperandrogenism in women by use of total testosterone concentrations measured by liquid chromatography-tandem mass spectrometry. Clin Chem. 2018;64(11):1636–1645. doi: 10.1373/clinchem.2018.290825
   PubMed Web of Science ®Google Scholar
• Redmond GP, Bergfeld WF. Diagnostic approach to androgen disorders in women: acne, hirsutism, and alopecia. Cleve Clin J Med. 1990;57(5):423–427. doi: 10.3949/ccjm.57.5.423
   PubMed Web of Science ®Google Scholar
• Elhassan YS, Idkowiak J, Smith K, et al. Causes, patterns, and severity of androgen excess in 1205 consecutively recruited women. J Clin Endocrinol Metab. 2018;103(3):1214–1223. doi: 10.1210/jc.2017-02426
   PubMed Web of Science ®Google Scholar
• Matteri RK, Stanczyk FZ, Gentzschein EE, et al. Androgen sulfate and glucuronide conjugates in nonhirsute and hirsute women with polycystic ovarian syndrome. Am J Obstet Gynecol. 1989;16:1704–1709. doi: 10.1016/0002-9378(89)90954-X
   Google Scholar
• Vexiau P, Chaspoux C, Boudou P, et al. Role of androgens in female-pattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism. Arch Dermatol Res. 2000;292(12):598–604. doi: 10.1007/s004030000184
   PubMed Web of Science ®Google Scholar
• Azziz R, Hincapie LA, Knochenhauer ES, et al. Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study. Fertil Steril. 1999;72:915–925. doi: 10.1016/S0015-0282(99)00383-0
   PubMed Web of Science ®Google Scholar
• Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273–288. doi: 10.1210/jc.2010-1692
   PubMed Web of Science ®Google Scholar
• Dumont A, Robin G, Catteau-Jonard S, et al. Role of anti-müllerian hormone in pathophysiology, diagnosis and treatment of polycystic ovary syndrome: a review. Reprod Biol Endocrinol. 2015;13(1):137. doi: 10.1186/s12958-015-0134-9
   PubMedGoogle Scholar
• Sahmay S, Aydin Y, Oncul M, et al. Diagnosis of polycystic ovary syndrome: AMH in combination with clinical symptoms. J Assist Reprod Genet. 2014;31(2):213–220. doi: 10.1007/s10815-013-0149-0
   PubMed Web of Science ®Google Scholar
• Anand S, Kumar A, Prasad A, et al. Updated meta-analysis on the diagnostic accuracy of serum anti-mullerian hormone in poly cystic ovary syndrome involving 13 509 subjects. J Obstet Gynaecol Res. 2022;48:2162–2174.
   PubMed Web of Science ®Google Scholar
• Chang AY. Polycsytic ovarian syndrome. In: Lavin N, editor. Manual of endocrinology and metabolism. Norman Lavin. 5th edn ed. Wolter Kluwer; 2019. p. 301–304.
   Google Scholar
• Cussen L, McDonnell T, Bennett G, et al. Approach to androgen excess in women: clinical and biochemical insights. Clin Endocrinol (Oxf). 2022;97(2):174–186. doi: 10.1111/cen.14710
   PubMed Web of Science ®Google Scholar
• Cibula D, Hill M, Starka L. The best correlation of the new index of hyperandrogenism with the grade of increased body hair. Eur J Endocrinol. 2000;143:405–408. doi: 10.1530/eje.0.1430405
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, Carmina E, Dewailly D, et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the androgen excess and polycystic ovary syndrome society. Hum Reprod Update. 2012;18(2):146–170. doi: 10.1093/humupd/dmr042
   PubMed Web of Science ®Google Scholar
• Amiri M, Ramezani Tehrani F, Nahidi F, et al. Association between biochemical hyperandrogenism parameters and Ferriman-Gallwey score in patients with polycystic ovary syndrome: a systematic review and meta-regression analysis. Clin Endocrinol (Oxf). 2017;87(3):217–230. doi: 10.1111/cen.13389
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab. 2006;91(11):4237–4245. doi: 10.1210/jc.2006-0178
   PubMed Web of Science ®Google Scholar
• Rosner W, Auchus RJ, Azziz R, et al. Position statement: utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. J Clin Endocrinol Metab. 2007;92(2):405–413. doi: 10.1210/jc.2006-1864
   PubMed Web of Science ®Google Scholar
• Stanczyk FZ, Lee JS, Santen RJ. Standardization of steroid hormone assays: why, how, and when? Cancer Epidemiol Biomarkers Prev. 2007;16(9):1713–1719. doi: 10.1158/1055-9965.EPI-06-0765
   PubMed Web of Science ®Google Scholar
• Legro RS, Schlaff WD, Diamond MP, et al. Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism. J Clin Endocrinol Metab. 2010;95(12):5305–5313. doi: 10.1210/jc.2010-1123
   PubMed Web of Science ®Google Scholar
• Griffing GT, Melby JC. Hirsutism causes and treatments. Hosp Pract (Off Ed). 1991;26:43–58.
   PubMed Web of Science ®Google Scholar
• Wild RA, Umstot ES, Andersen RN, et al. Androgen parameters and their correlation with body weight in one hundred thirty-eight women thought to have hyperandrogenism. Am J Obstet Gynecol. 1983;146(6):602–606. doi: 10.1016/0002-9378(83)90998-5
   PubMed Web of Science ®Google Scholar
• Bailey-Pridham DD, Sanfilippo JS. Hirsutism in the adolescent female. Pediatr Clin North Am. 1989;36(3):581–599. doi: 10.1016/S0031-3955(16)36687-1
   PubMed Web of Science ®Google Scholar
• Lemay A, Dewailly SD, Grenier R, et al. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel. J Clin Endocrinol Metab. 1990;71(1):8–14. doi: 10.1210/jcem-71-1-8
   PubMed Web of Science ®Google Scholar
• Reingold SB, Rosenfield RL. The relationship of mild hirsutism or acne in women to androgens. Arch Dermatol. 1987;123:209–212. doi: 10.1001/archderm.1987.01660260079018
   PubMed Web of Science ®Google Scholar
• Levell MJ, Cawood ML, Burke B, et al. Acne is not associated with abnormal plasma androgens. Br J Dermatol. 1989;120(5):649–654. doi: 10.1111/j.1365-2133.1989.tb01351.x
   PubMed Web of Science ®Google Scholar
• Rittmaster RS, Loriaux DL. Hirsutism. Ann Intern Med. 1987;106:95–107. doi: 10.7326/0003-4819-106-1-95
   PubMed Web of Science ®Google Scholar
• Selby C. Sex hormone binding globulin: origin, function and clinical significance. Ann Clin Biochem. 1990;27(6):532–541. doi: 10.1177/000456329002700603
   PubMedGoogle Scholar
• Gupta MK. Androgen assessment in hirsutism and alopecia. Cleve Clin J Med. 1990;57(3):292–297. doi: 10.3949/ccjm.57.3.292
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666–3672. doi: 10.1210/jcem.84.10.6079
   PubMed Web of Science ®Google Scholar
• Miller KK, Rosner W, Lee H, et al. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab. 2004;89(2):525–533. doi: 10.1210/jc.2003-030680
   PubMed Web of Science ®Google Scholar
• Chang WY, Knochenhauer ES, Bartolucci AA, et al. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril. 2005;83(6):1717–1723. doi: 10.1016/j.fertnstert.2005.01.096
   PubMed Web of Science ®Google Scholar
• Pasquali R, Zanotti L, Fanelli F, et al. Defining hyperandrogenism in women with polycystic ovary syndrome: a challenging perspective. J Clin Endocrinol Metab. 2016;101(5):2013–2022. doi: 10.1210/jc.2015-4009
   PubMed Web of Science ®Google Scholar
• Schwartz U, Moltz L, Brotherton J, et al. The diagnostic value of plasma free testosterone in non-tumorous and tumorous hyperandrogenism. Fertil Steril. 1983;40(1):66–72. doi: 10.1016/S0015-0282(16)47179-7
   PubMed Web of Science ®Google Scholar
• Keevil BG, Adaway J, Fiers T, et al. The free androgen index is inaccurate in women when the SHBG concentration is low. Clin Endocrinol (Oxf). 2018;88(5):706–710. doi: 10.1111/cen.13561
   PubMed Web of Science ®Google Scholar
• Fogh H, Worm AM, Forkert B, et al. Androgens in hirsute women referred for electroepilation. Acta Derm Venereol. 1989;69:179–182.
   PubMed Web of Science ®Google Scholar
• Blight LF, Judd SJ, White GH. Relative diagnostic value of serum non-SHBG-bound testosterone, free androgen index and free testosterone in the assessment of mild to moderate hirsutism. Ann Clin Biochem. 1989;26(Pt 4):311–316. doi: 10.1177/000456328902600402
   PubMedGoogle Scholar
• Kirschner MA, Bardin CW. Androgen production and metabolism in normal and virilized women. Metabolism. 1972;21(7):667–688. doi: 10.1016/0026-0495(72)90090-X
   PubMed Web of Science ®Google Scholar
• Artar G, Tas B, Turan G, et al. Evaluation of androgen-dependent skin findings of polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2022;29:1–5. doi: 10.1080/09513590.2022.2162496
   Google Scholar
• Bansal P, Sardana K, Sharma L, et al. A prospective study examining isolated acne and acne with hyperandrogenic signs in adult females. J DermatolTreat. 2021;32(7):752–755. doi: 10.1080/09546634.2019.1708245
   Google Scholar
• Santoro N, Banwell T, Tortoriello D, et al. Effects of aging and gonadal failure on the hypothalamic-pituitary axis in women. Am J Obstet Gynecol. 1998;178(4):732–741. doi: 10.1016/S0002-9378(98)70483-1
   PubMed Web of Science ®Google Scholar
• Marynick SP, Chakmakjian ZH, McCaffree DL, et al. Androgen excess in cystic acne. N Engl J Med. 1983;308:981–986. doi: 10.1056/NEJM198304283081701
   PubMed Web of Science ®Google Scholar
• Medda F, Nieddu R, Fiore R, et al. Hormonal profile and androgen status during the menstrual cycle in women with acne. Clin Exp Obstet Gynecol. 1988;15:137–142.
   PubMedGoogle Scholar
• Laue L, Peck GL, Loriaux DL, et al. Adrenal androgen secretion in postadolescent acne: increased adrenocortical function without hypersensitivity to adrenocorticotropin. J Clin Endocrinol Metab. 1991;73(2):380–384. doi: 10.1210/jcem-73-2-380
   PubMed Web of Science ®Google Scholar
• Maroulis GB, Maroulis GB. Evaluation of hirsutism and hyperandrogenemia. FertilSteril. 1981;36:273–305. doi: 10.1016/S0015-0282(16)45728-6
   PubMed Web of Science ®Google Scholar
• Khandekar S, Lata V, Dash RJ. Circulating androgens in hirsutism. J Assoc Physicians India. 1989;37:632–635.
   PubMedGoogle Scholar
• O’Reilly MW, Taylor AE, Crabtree NJ, et al. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione. J Clin Endocrinol Metab. 2014;99(3):1027–1036. doi: 10.1210/jc.2013-3399
   PubMed Web of Science ®Google Scholar
• Joura EA, Geusau A, Schneider B, et al. Serum 3 alpha-androstanediol-glucuronide is decreased in nonhirsute women with acne vulgaris. Fertil Steril. 1996;66:1033-1035–6. doi: 10.1016/S0015-0282(16)58705-6
   PubMed Web of Science ®Google Scholar
• Maffazioli GDN, Bachega T, Hayashida SAY, et al. Steroid screening tools differentiating nonclassical congenital adrenal hyperplasia and polycystic ovary syndrome. J Clin Endocrinol Metab. 2020;105:dgaa369. doi: 10.1210/clinem/dgaa369
   PubMed Web of Science ®Google Scholar
• Carmina E, Dewailly D, Escobar-Morreale HF, et al. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women. Hum Reprod Update. 2017;23(5):580–599. doi: 10.1093/humupd/dmx014
   PubMed Web of Science ®Google Scholar
• Chen K, Chen S, Lu L, et al. An optimized pathway for the differential diagnosis of ACTH-dependent cushing’s syndrome based on low-dose dexamethasone suppression test. Front Endocrinol. 2021;12:720823. doi: 10.3389/fendo.2021.720823
   PubMed Web of Science ®Google Scholar
• Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364–389. doi: 10.1210/jc.2015-1710
   PubMed Web of Science ®Google Scholar
• Polan ML, Behrman HR. Prolactin-stimulated ovarian androgen metabolism. Am J Obstet Gynecol. 1981;139(4):487–491. doi: 10.1016/0002-9378(81)90330-6
   PubMed Web of Science ®Google Scholar
• Gruijters MJ, Visser JA, Durlinger AL, et al. Anti-Müllerian hormone and its role in ovarian function. Mol Cell Endocrinol. 2003;211:85–90. doi: 10.1016/j.mce.2003.09.024
   PubMed Web of Science ®Google Scholar
• Pigny P, Merlen E, Robert Y, et al. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab. 2003;88(12):5957–5962. doi: 10.1210/jc.2003-030727
   PubMed Web of Science ®Google Scholar
• Bansal P, Sardana K, Arora P, et al. A prospective study of anti-mullerian hormone and other ovarian and adrenal hormones in adult female acne. Dermatol Ther. 2020;33(6):e13974. doi: 10.1111/dth.13974
   PubMed Web of Science ®Google Scholar
• Zhang M, Liu X, Xu X, et al. The reference value of anti-Müllerian hormone to diagnose polycystic ovary syndrome is inversely associated with BMI: a retrospective study. Reprod Biol Endocrinol. 2023;21(1):15. doi: 10.1186/s12958-023-01064-y
   PubMed Web of Science ®Google Scholar
• Ramezani Tehrani F, Rahmati M, Mahboobifard F, et al. Age-specific cut-off levels of anti-Müllerian hormone can be used as diagnostic markers for polycystic ovary syndrome. Reprod Biol Endocrinol. 2021;19(1):76. doi: 10.1186/s12958-021-00755-8
   PubMed Web of Science ®Google Scholar
• Jacob SL, Field HP, Calder N, et al. Anti-Müllerian hormone reflects the severity of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2017;86(3):395–400. doi: 10.1111/cen.13269
   PubMed Web of Science ®Google Scholar
• Yue CY, Lu LK, Li M, et al. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women. PLoS One. 2018;13:e0203129. doi: 10.1371/journal.pone.0203129
   PubMed Web of Science ®Google Scholar
• van den Berg MH, van Dulmen-den Broeder E, Overbeek A, et al. Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases. Hum Reprod. 2010;25:1520–1527. doi: 10.1093/humrep/deq071
   PubMed Web of Science ®Google Scholar
• Visser JA, Schipper I, Laven JS, et al. Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol. 2012;8:331–341. doi: 10.1038/nrendo.2011.224
   PubMed Web of Science ®Google Scholar
• Tsukui Y, Kitahara Y, Hasegawa Y, et al. Anti-Müllerian hormone levels in the diagnosis of adolescent polycystic ovarian syndrome: a systematic review and meta-analysis. Endocr J. 2022;69(8):897–906. doi: 10.1507/endocrj.EJ22-0081
   PubMed Web of Science ®Google Scholar
• Dumesic DA, Oberfield SE, Stener-Victorin E, et al. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36(5):487–525. doi: 10.1210/er.2015-1018
   PubMed Web of Science ®Google Scholar
• Taylor AE, McCourt B, Martin KA, et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997;82:2248–2256. doi: 10.1210/jc.82.7.2248
   PubMed Web of Science ®Google Scholar
• Outwater EK, Wagner BJ, Mannion C, et al. Sex cord-stromal and steroid cell tumors of the ovary. Radiographics. 1998;18(6):1523–1546. doi: 10.1148/radiographics.18.6.9821198
   PubMed Web of Science ®Google Scholar
• Prassopoulos V, Laspas F, Vlachou F, et al. Leydig cell tumour of the ovary localised with positron emission tomography/computed tomography. Gynecol Endocrinol. 2011;27(10):837–839. doi: 10.3109/09513590.2010.521263
   PubMed Web of Science ®Google Scholar
• Bancos I, Taylor AE, Chortis V, et al. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study. Lancet Diabetes Endocrinol. 2020;8(9):773–781. doi: 10.1016/S2213-8587(20)30218-7
   PubMed Web of Science ®Google Scholar
• Rennert J, Doerfler A. Imaging of sellar and parasellar lesions. Clin Neurol Neurosur. 2007;109(2):111–124. doi: 10.1016/j.clineuro.2006.11.001
   PubMed Web of Science ®Google Scholar
• Bricaire C, Raynaud A, Benotmane A, et al. Selective venous catheterization in the evaluation of hyperandrogenism. J Endocrinol Invest. 1991;14(11):949–956. doi: 10.1007/BF03347121
   PubMed Web of Science ®Google Scholar
• Taylor L, Ayers JW, Gross MD, et al. Diagnostic considerations in virilization: iodomethyl-norcholesterol scanning in the localization of androgen secreting tumors. Fertil Steril. 1986;46:1005–1010. doi: 10.1016/S0015-0282(16)49871-7
   PubMed Web of Science ®Google Scholar
• Merhi ZO, Santoro N. Postmenopausal virilization after spousal use of topical androgens. Fertil Steril. 2007;87:976.e13–5. doi: 10.1016/j.fertnstert.2006.07.1547
   PubMed Web of Science ®Google Scholar
• Karrer-Voegeli S, Rey F, Reymond MJ, et al. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism. Medicine (Baltimore). 2009;88(1):32–45. doi: 10.1097/md.0b013e3181946a2c
   PubMed Web of Science ®Google Scholar
• Stuenkel CA, Manson JE. Compounded bioidentical hormone therapy: does the regulatory double standard harm women? JAMA Intern Med. 2017;177(12):1719–1720. doi: 10.1001/jamainternmed.2017.5141
   PubMed Web of Science ®Google Scholar
• Smit DL, Buijs MM, de Hon O, et al. Positive and negative side effects of androgen abuse. The HAARLEM study: a one-year prospective cohort study in 100 men. Scand J Med Sci Sports. 2021;31(2):427–438. doi: 10.1111/sms.13843
   PubMed Web of Science ®Google Scholar
• Carmina E, Gonzalez F, Chang L, et al. Reassessment of adrenal androgen secretion in women with polycystic ovary syndrome. Obstet Gynecol. 1995;85(6):971–976. doi: 10.1016/0029-7844(95)00065-Y
   PubMed Web of Science ®Google Scholar
• Carmina E. Ovarian and adrenal hyperandrogenism. Ann N Y Acad Sci. 2006;1092(1):130–137. doi: 10.1196/annals.1365.011
   PubMedGoogle Scholar
• Rosner W. Letter to the editor: an extraordinarily inaccurate assay for free testosterone is still with us. J Clin Endocrinol Metab. 2001;86(6):2903. doi: 10.1210/jcem.86.6.7643
   PubMed Web of Science ®Google Scholar
• Morley JE, Patrick P, Perry HM. Evaluation of assays available to measure free testosterone. Metabolism. 2002;51:554–559. doi: 10.1053/meta.2002.31975
   PubMed Web of Science ®Google Scholar
• Horton R, Hawks D, Lobo R. 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism. J Clin Invest. 1982;69(5):1203–1206. doi: 10.1172/JCI110558
   PubMed Web of Science ®Google Scholar
• Kamilaris TC, DeBold CR, Manolas KJ, et al. Testosterone-secreting adrenal adenoma in a peripubertal girl. JAMA. 1987;258:2558–2561. doi: 10.1001/jama.1987.03400180092034
   PubMed Web of Science ®Google Scholar
• Kaltsas GA, Mukherjee JJ, Kola B, et al. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women? Clin Endocrinol (Oxf). 2003;59(1):34–43. doi: 10.1046/j.1365-2265.2003.01792.x
   PubMed Web of Science ®Google Scholar